Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Product revenues	$ 7,654	$ 6,744	$ 13,435	$ 12,718
Service revenues	7,050	3,972	13,890	6,015
Total revenues	14,704	10,716	27,325	18,733
Cost of sales	5,628	3,385	10,513	5,680
Gross profit	9,076	7,331	16,812	13,053
Operating expenses:
Selling, general and administrative	6,139	6,836	12,250	11,587
Research and development	2,128	2,345	4,306	4,125
Change in fair value of contingent consideration	(2,156)		400
Total operating expenses	6,111	9,181	16,956	15,712
Operating income (loss)	2,965	(1,850)	(144)	(2,659)
Interest expense, net	(117)	(95)	(244)	(109)
Other income (loss), net	68	(39)	(1)	(122)
Income (loss) before taxes	2,916	(1,984)	(389)	(2,890)
Income tax benefit (expense), net	37	(93)	125	(104)
Net income (loss)	2,953	(2,077)	(264)	(2,994)
Less: Net income attributable to Non-controlling interests	6	8	31	8
Net income (loss) attributable to ChyronHego shareholders	$ 2,947	$ (2,085)	$ (295)	$ (3,002)
Net income (loss) per share attributable to ChyronHego shareholders - basic (in Dollars per share)	$ 0.08	$ (0.09)	$ (0.01)	$ (0.15)
Net income (loss) per share attributable to ChyronHego shareholders - diluted (in Dollars per share)	$ 0.08	$ (0.09)	$ (0.01)	$ (0.15)
Weighted average shares outstanding:
Basic (in Shares)	35,089	22,989	33,114	20,191
Diluted (in Shares)	36,090	22,989	33,114	20,191